{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:39:25Z","timestamp":1793320765692,"version":"4.5.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"JSS Academy of Higher Education and Research, Mysore"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Brain Res"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00221-026-07327-5","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:40:23Z","timestamp":1780735223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular neurobiological insights on integrative role of Trk neurotrophic receptors and their small-molecule agonists in neurodegenerative conditions"],"prefix":"10.1007","volume":"244","author":[{"given":"Megha","family":"Sanjai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeyaram Bharathi","family":"Jeyabalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh Pandi","family":"Alagesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruthi Laya","family":"Saravanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Premdoss","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Justin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"7327_CR94","doi-asserted-by":"publisher","unstructured":"Albin.(2022) Parkinson Disease. Oxf Univ PressNew York iv\u2013iv. https:\/\/doi.org\/10.1093\/med\/9780190843014.002.0004","DOI":"10.1093\/med\/9780190843014.002.0004"},{"issue":"22","key":"7327_CR1","doi-asserted-by":"publisher","first-page":"12583","DOI":"10.1021\/acsomega.0c01592","volume":"5","author":"J Ahlawat","year":"2020","unstructured":"Ahlawat J, Guillama Barroso G, Masoudi Asil S, Alvarado M, Armendariz I, Bernal J, Carabaza X, Chavez S, Cruz P, Escalante V, Estorga S, Fernandez D, Lozano C, Marrufo M, Ahmad N, Negrete S, Olvera K, Parada X, Portillo B, Narayan M (2020) Nanocarriers as potential drug delivery candidates for overcoming the blood\u2013brain barrier: challenges and possibilities. ACS Omega 5(22):12583\u201312595. https:\/\/doi.org\/10.1021\/acsomega.0c01592","journal-title":"ACS Omega"},{"issue":"1","key":"7327_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.expneurol.2011.06.006","volume":"235","author":"F Akbik","year":"2012","unstructured":"Akbik F, Cafferty WBJ, Strittmatter SM (2012) Myelin associated inhibitors: a link between injury-induced and experience-dependent plasticity. Exp Neurol 235(1):43\u201352. https:\/\/doi.org\/10.1016\/j.expneurol.2011.06.006","journal-title":"Exp Neurol"},{"key":"7327_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.expneurol.2018.06.002","volume":"307","author":"O Akyol","year":"2018","unstructured":"Akyol O, Sherchan P, Yilmaz G, Reis C, Ho WM, Wang Y, Huang L, Solaroglu I, Zhang JH (2018) Neurotrophin-3 provides neuroprotection via TrkC receptor dependent pErk5 activation in a rat surgical brain injury model. Exp Neurol 307:82\u201389. https:\/\/doi.org\/10.1016\/j.expneurol.2018.06.002","journal-title":"Exp Neurol"},{"issue":"5","key":"7327_CR4","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1007\/s12035-023-03727-8","volume":"61","author":"NH Ali","year":"2024","unstructured":"Ali NH, Al-kuraishy HM, Al-Gareeb AI, Alnaaim SA, Saad HM, Batiha GE-S (2024) The molecular pathway of p75 neurotrophin receptor (p75NTR) in parkinson\u2019s disease: the way of new inroads. Mol Neurobiol 61(5):2469\u20132480. https:\/\/doi.org\/10.1007\/s12035-023-03727-8","journal-title":"Mol Neurobiol"},{"key":"7327_CR5","doi-asserted-by":"publisher","unstructured":"Almeida RD, Duarte CB (2014) p75NTR Processing and signaling: functional role. In: Handbook of Neurotoxicity. Springer New York, p. 1899\u20131923 https:\/\/doi.org\/10.1007\/978-1-4614-5836-4_25","DOI":"10.1007\/978-1-4614-5836-4_25"},{"issue":"12","key":"7327_CR6","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S0969-2126(01)00681-5","volume":"9","author":"MJ Banfield","year":"2001","unstructured":"Banfield MJ, Naylor RL, Robertson AGS, Allen SJ, Dawbarn D, Brady RL (2001) Specificity in Trk receptor: neurotrophin interactions. Structure 9(12):1191\u20131199. https:\/\/doi.org\/10.1016\/S0969-2126(01)00681-5","journal-title":"Structure"},{"key":"7327_CR7","first-page":"45","volume":"390","author":"YA Barde","year":"1994","unstructured":"Barde YA (1994) Neurotrophins: a family of proteins supporting the survival of neurons. Prog Clin Biol Res 390:45\u201356","journal-title":"Prog Clin Biol Res"},{"key":"7327_CR8","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.12688\/f1000research.8434.1","volume":"5","author":"M Bothwell","year":"2016","unstructured":"Bothwell M (2016) Recent advances in understanding neurotrophin signaling. F1000Research 5:1885. https:\/\/doi.org\/10.12688\/f1000research.8434.1","journal-title":"F1000Research"},{"issue":"10","key":"7327_CR9","doi-asserted-by":"publisher","first-page":"e0162307","DOI":"10.1371\/journal.pone.0162307","volume":"11","author":"F Brahimi","year":"2016","unstructured":"Brahimi F, Maira M, Barcelona PF, Galan A, Aboulkassim T, Teske K, Rogers M-L, Bertram L, Wang J, Yousefi M, Rush R, Fabian M, Cashman N, Saragovi HU (2016) The paradoxical signals of two TrkC receptor isoforms supports a rationale for novel therapeutic strategies in ALS. PLoS ONE 11(10):e0162307. https:\/\/doi.org\/10.1371\/journal.pone.0162307","journal-title":"PLoS ONE"},{"issue":"10","key":"7327_CR10","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1172\/JCI74809","volume":"124","author":"V Brito","year":"2014","unstructured":"Brito V, Giralt A, Enriquez-Barreto L, Puigdell\u00edvol M, Suelves N, Zamora-Moratalla A, Ballesteros JJ, Mart\u00edn ED, Dominguez-Iturza N, Morales M, Alberch J, Gin\u00e9s S (2014) Neurotrophin receptor p75NTR mediates Huntington\u2019s disease\u2013associated synaptic and memory dysfunction. J Clin Invest 124(10):4411\u20134428. https:\/\/doi.org\/10.1172\/JCI74809","journal-title":"J Clin Invest"},{"issue":"48","key":"7327_CR11","doi-asserted-by":"publisher","first-page":"16846","DOI":"10.1021\/bi981254o","volume":"37","author":"MJ Butte","year":"1998","unstructured":"Butte MJ, Hwang PK, Mobley WC, Fletterick RJ (1998) Crystal structure of neurotrophin-3 homodimer shows distinct regions are used to bind its receptors. Biochemistry 37(48):16846\u201316852. https:\/\/doi.org\/10.1021\/bi981254o","journal-title":"Biochemistry"},{"issue":"6","key":"7327_CR12","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.3390\/ijms18061319","volume":"18","author":"N Canu","year":"2017","unstructured":"Canu N, Amadoro G, Triaca V, Latina V, Sposato V, Corsetti V, Severini C, Ciotti MT, Calissano P (2017) The intersection of NGF\/TrkA signaling and amyloid precursor protein processing in alzheimer\u2019s disease neuropathology. Int J Mol Sci 18(6):1319. https:\/\/doi.org\/10.3390\/ijms18061319","journal-title":"Int J Mol Sci"},{"issue":"3","key":"7327_CR13","doi-asserted-by":"publisher","first-page":"e91453","DOI":"10.1371\/journal.pone.0091453","volume":"9","author":"NA Castello","year":"2014","unstructured":"Castello NA, Nguyen MH, Tran JD, Cheng D, Green KN, LaFerla FM (2014) 7,8-Dihydroxyflavone, a small molecule TrkB agonist, improves spatial memory and increases thin spine density in a mouse model of Alzheimer disease-like neuronal loss. PLoS ONE 9(3):e91453. https:\/\/doi.org\/10.1371\/journal.pone.0091453","journal-title":"PLoS ONE"},{"issue":"7","key":"7327_CR14","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3390\/ph17070961","volume":"17","author":"GN Chaldakov","year":"2024","unstructured":"Chaldakov GN, Aloe L, Yanev SG, Fiore M, Tonchev AB, Vinciguerra M, Evtimov NT, Ghenev P, Dikranian K (2024) Trackins (Trk-targeting drugs): a novel therapy for different diseases. Pharmaceuticals 17(7):961. https:\/\/doi.org\/10.3390\/ph17070961","journal-title":"Pharmaceuticals"},{"issue":"4","key":"7327_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nmeth.3312","volume":"12","author":"A Chavez","year":"2015","unstructured":"Chavez A, Scheiman J, Vora S, Pruitt BW, Tuttle M, Iyer PR, Lin E, Kiani S, Guzman S, Wiegand CD, Ter-Ovanesyan DJ, Braff D, Davidsohn JL, Housden N, Perrimon BE, Weiss N, Aach R, Collins J, J. J., Church GM (2015) Highly efficient Cas9-mediated transcriptional programming. Nat Methods 12(4):326\u2013328. https:\/\/doi.org\/10.1038\/nmeth.3312","journal-title":"Nat Methods"},{"issue":"13","key":"7327_CR16","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1021\/acschemneuro.1c00181","volume":"12","author":"C Chen","year":"2021","unstructured":"Chen C, Ahn EH, Liu X, Wang Z-H, Luo S, Liao J, Ye K (2021) Optimized TrkB agonist ameliorates Alzheimer\u2019s disease pathologies and improves cognitive functions via inhibiting delta-secretase. ACS Chem Neurosci 12(13):2448\u20132461. https:\/\/doi.org\/10.1021\/acschemneuro.1c00181","journal-title":"ACS Chem Neurosci"},{"issue":"9","key":"7327_CR17","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1073\/pnas.42.9.571","volume":"42","author":"S Cohen","year":"1956","unstructured":"Cohen S, Levi-Montalcini R (1956) A nerve growth-stimulating factor isolated from snake venom. Proc Natl Acad Sci 42(9):571\u2013574. https:\/\/doi.org\/10.1073\/pnas.42.9.571","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"7327_CR18","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0306-4522(02)00755-8","volume":"116","author":"JCVM Copray","year":"2003","unstructured":"Copray JCVM, Jaarsma D, Kst BM, Bruggeman RWG, Mantingh I, Brouwer N, Boddeke HWGM (2003) Expression of the low affinity neurotrophin receptor p75 in spinal motoneurons in a transgenic mouse model for amyotrophic lateral sclerosis. Neuroscience 116(3):685\u2013694. https:\/\/doi.org\/10.1016\/S0306-4522(02)00755-8","journal-title":"Neuroscience"},{"key":"7327_CR19","doi-asserted-by":"publisher","first-page":"1305574","DOI":"10.3389\/fnmol.2023.1305574","volume":"16","author":"V Danelon","year":"2023","unstructured":"Danelon V, Garret-Thomson SC, Almo SC, Lee FS, Hempstead BL (2023) Immune activation of the p75 neurotrophin receptor: implications in neuroinflammation. Front Mol Neurosci 16:1305574. https:\/\/doi.org\/10.3389\/fnmol.2023.1305574","journal-title":"Front Mol Neurosci"},{"issue":"5","key":"7327_CR57","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3390\/ijms18051028","volume":"18","author":"G De Minnone","year":"2017","unstructured":"Minnone G, De Benedetti F, Bracci-Laudiero L (2017) NGF and Its receptors in the regulation of inflammatory response. Int J Mol Sci 18(5):1028. https:\/\/doi.org\/10.3390\/ijms18051028","journal-title":"Int J Mol Sci"},{"issue":"9","key":"7327_CR95","doi-asserted-by":"publisher","first-page":"e1005357","DOI":"10.1371\/journal.pgen.1005357","volume":"11","author":"J Deng","year":"2015","unstructured":"Deng J, Yang M, Chen Y, Chen X, Liu J, Sun S, Cheng H, Li Y, Bigio EH, Mesulam M, Xu Q, Du S, Fushimi K, Zhu L, Wu JY (2015) FUS Interacts with HSP60 to Promote Mitochondrial Damage. PLoS Genet 11(9):e1005357. https:\/\/doi.org\/10.1371\/journal.pgen.1005357","journal-title":"PLoS Genet"},{"issue":"8","key":"7327_CR20","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3390\/ph17080997","volume":"17","author":"P Forsell","year":"2024","unstructured":"Forsell P, Parrado Fern\u00e1ndez C, Nilsson B, Sandin J, Nordvall G, Segerdahl M (2024) Positive allosteric modulators of Trk receptors for the treatment of alzheimer\u2019s disease. Pharmaceuticals 17(8):997. https:\/\/doi.org\/10.3390\/ph17080997","journal-title":"Pharmaceuticals"},{"issue":"2","key":"7327_CR21","doi-asserted-by":"publisher","first-page":"100926","DOI":"10.1016\/j.jbc.2021.100926","volume":"297","author":"ML Franco","year":"2021","unstructured":"Franco ML, Nadezhdin KD, Light TP, Goncharuk SA, Soler-Lopez A, Ahmed F, Mineev KS, Hristova K, Arseniev AS, Vilar M (2021) Interaction between the transmembrane domains of neurotrophin receptors p75 and TrkA mediates their reciprocal activation. J Biol Chem 297(2):100926. https:\/\/doi.org\/10.1016\/j.jbc.2021.100926","journal-title":"J Biol Chem"},{"issue":"2","key":"7327_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/5532","volume":"5","author":"CP Genain","year":"1999","unstructured":"Genain CP, Cannella B, Hauser SL, Raine CS (1999) Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med 5(2):170\u2013175. https:\/\/doi.org\/10.1038\/5532","journal-title":"Nat Med"},{"issue":"11","key":"7327_CR23","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","volume":"27","author":"JM Gil","year":"2008","unstructured":"Gil JM, Rego AC (2008) Mechanisms of neurodegeneration in Huntington\u2019s disease. Eur J Neurosci 27(11):2803\u20132820. https:\/\/doi.org\/10.1111\/j.1460-9568.2008.06310.x","journal-title":"Eur J Neurosci"},{"issue":"8","key":"7327_CR24","doi-asserted-by":"publisher","first-page":"a024117","DOI":"10.1101\/cshperspect.a024117","volume":"7","author":"LI Grad","year":"2017","unstructured":"Grad LI, Rouleau GA, Ravits J, Cashman NR (2017) Clinical spectrum of amyotrophic lateral sclerosis (ALS). Cold Spring Harbor Perspect Med 7(8):a024117. https:\/\/doi.org\/10.1101\/cshperspect.a024117","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"1","key":"7327_CR25","doi-asserted-by":"publisher","first-page":"ENEURO0257","DOI":"10.1523\/ENEURO.0257-17.2017","volume":"5","author":"SG Greenwood","year":"2018","unstructured":"Greenwood SG, Montroull L, Volosin M, Scharfman HE, Teng KK, Light M, Torkin R, Maxfield F, Hempstead BL, Friedman WJ (2018) A novel neuroprotective mechanism for lithium that prevents association of the p75 NTR-sortilin receptor complex and attenuates proNGF-induced neuronal death in vitro and in vivo. Eneuro 5(1):ENEURO0257\u2013172017. https:\/\/doi.org\/10.1523\/ENEURO.0257-17.2017","journal-title":"Eneuro"},{"key":"7327_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jbior.2017.08.003","volume":"66","author":"X Guo","year":"2017","unstructured":"Guo X, Namekata K, Kimura A, Harada C, Harada T (2017) ASK1 in neurodegeneration. Adv Biol Regul 66:63\u201371. https:\/\/doi.org\/10.1016\/j.jbior.2017.08.003","journal-title":"Adv Biol Regul"},{"issue":"17","key":"7327_CR27","doi-asserted-by":"publisher","first-page":"4816","DOI":"10.1523\/JNEUROSCI.4024-15.2016","volume":"36","author":"KA Han","year":"2016","unstructured":"Han KA, Woo D, Kim S, Choii G, Jeon S, Won SY, Kim HM, Heo W, Do, Um JW, Ko J (2016) Neurotrophin-3 regulates synapse development by modulating TrkC-PTP\u03c3 synaptic adhesion and intracellular signaling pathways. J Neurosci 36(17):4816\u20134831. https:\/\/doi.org\/10.1523\/JNEUROSCI.4024-15.2016","journal-title":"J Neurosci"},{"issue":"15","key":"7327_CR28","doi-asserted-by":"publisher","first-page":"8312","DOI":"10.3390\/ijms25158312","volume":"25","author":"C Hern\u00e1ndez-del Ca\u00f1o","year":"2024","unstructured":"Hern\u00e1ndez-del Ca\u00f1o C, Varela-Andr\u00e9s N, Cebri\u00e1n-Le\u00f3n A, Deogracias R (2024) Neurotrophins and Their receptors: BDNF\u2019s role in GABAergic neurodevelopment and disease. Int J Mol Sci 25(15):8312. https:\/\/doi.org\/10.3390\/ijms25158312","journal-title":"Int J Mol Sci"},{"issue":"1","key":"7327_CR97","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","volume":"24","author":"EJ Huang","year":"2001","unstructured":"Huang EJ, Reichardt LF (2001b) Neurotrophins: Roles in Neuronal Development and Function. Annu Rev Neurosci 24(1):677\u2013736. https:\/\/doi.org\/10.1146\/annurev.neuro.24.1.677","journal-title":"Annu Rev Neurosci"},{"key":"7327_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","volume":"24","author":"EJ Huang","year":"2001","unstructured":"Huang EJ, Reichardt LF (2001a) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677\u2013736. https:\/\/doi.org\/10.1146\/annurev.neuro.24.1.677","journal-title":"Annu Rev Neurosci"},{"issue":"41","key":"7327_CR32","doi-asserted-by":"publisher","first-page":"16329","DOI":"10.1073\/pnas.0706662104","volume":"104","author":"S-W Jang","year":"2007","unstructured":"Jang S-W, Okada M, Sayeed I, Xiao G, Stein D, Jin P, Ye K (2007) Gambogic amide, a selective agonist for TrkA receptor that possesses robust neurotrophic activity, prevents neuronal cell death. Proc Natl Acad Sci 104(41):16329\u201316334. https:\/\/doi.org\/10.1073\/pnas.0706662104","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"7327_CR31","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.chembiol.2009.05.010","volume":"16","author":"S-W Jang","year":"2009","unstructured":"Jang S-W, Liu X, Chan C-B, Weinshenker D, Hall RA, Xiao G, Ye K (2009) Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA\/TrkB heterodimerization and has potent neurotrophic activity. Chem Biol 16(6):644\u2013656. https:\/\/doi.org\/10.1016\/j.chembiol.2009.05.010","journal-title":"Chem Biol"},{"key":"7327_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.17879\/freeneuropathology-2020-3050","volume":"1","author":"KA Jellinger","year":"2020","unstructured":"Jellinger KA (2020) Neuropathology of the Alzheimer\u2019s continuum: an update. Free Neuropathology 1:32. https:\/\/doi.org\/10.17879\/freeneuropathology-2020-3050","journal-title":"Free Neuropathology"},{"key":"7327_CR98","doi-asserted-by":"publisher","unstructured":"Jeyaram Bharathi J, Antony J (2022) TrkA Signalling and Parkinson\u2019s Dementia. In Dementia in Parkinson\u2019s Disease - Everything you Need to Know. IntechOpen https:\/\/doi.org\/10.5772\/intechopen.99106","DOI":"10.5772\/intechopen.99106"},{"key":"7327_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.nbd.2016.08.004","volume":"97","author":"S Josephy-Hernandez","year":"2017","unstructured":"Josephy-Hernandez S, Jmaeff S, Pirvulescu I, Aboulkassim T, Saragovi HU (2017) Neurotrophin receptor agonists and antagonists as therapeutic agents: An evolving paradigm. Neurobiol Dis 97:139\u2013155. https:\/\/doi.org\/10.1016\/j.nbd.2016.08.004","journal-title":"Neurobiol Dis"},{"issue":"1","key":"7327_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10072-018-3585-x","volume":"40","author":"R Kaur","year":"2019","unstructured":"Kaur R, Mehan S, Singh S (2019) Understanding multifactorial architecture of Parkinson\u2019s disease: pathophysiology to management. Neurol Sci 40(1):13\u201323. https:\/\/doi.org\/10.1007\/s10072-018-3585-x","journal-title":"Neurol Sci"},{"issue":"10","key":"7327_CR36","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm1651","volume":"13","author":"H Kebir","year":"2007","unstructured":"Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F, Arbour N, Becher B, Prat A (2007) Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13(10):1173\u20131175. https:\/\/doi.org\/10.1038\/nm1651","journal-title":"Nat Med"},{"issue":"1","key":"7327_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12035-025-05417-z","volume":"63","author":"U Kochman","year":"2026","unstructured":"Kochman U, Sitka H, Ku\u017aniar J, Czaja M, Kozubek P, Besz\u0142ej JA, Leszek J (2026) Targeted nanoparticles for drug delivery across the blood\u2013brain barrier in early and late stages of Alzheimer\u2019s disease: a review. Mol Neurobiol 63(1):75. https:\/\/doi.org\/10.1007\/s12035-025-05417-z","journal-title":"Mol Neurobiol"},{"issue":"22","key":"7327_CR38","doi-asserted-by":"publisher","first-page":"9721","DOI":"10.1523\/JNEUROSCI.22-22-09721.2002","volume":"22","author":"NH Komiyama","year":"2002","unstructured":"Komiyama NH, Watabe AM, Carlisle HJ, Porter K, Charlesworth P, Monti J, Strathdee DJC, O\u2019Carroll CM, Martin SJ, Morris RGM, O\u2019Dell TJ, Grant SG N (2002) SynGAP regulates ERK\/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density 95 and NMDA receptor. J Neurosci 22(22):9721\u20139732. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-22-09721.2002","journal-title":"J Neurosci"},{"issue":"7536","key":"7327_CR39","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nature14136","volume":"517","author":"S Konermann","year":"2015","unstructured":"Konermann S, Brigham MD, Trevino AE, Joung J, Abudayyeh OO, Barcena C, Hsu PD, Habib N, Gootenberg JS, Nishimasu H, Nureki O, Zhang F (2015) Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517(7536):583\u2013588. https:\/\/doi.org\/10.1038\/nature14136","journal-title":"Nature"},{"issue":"1","key":"7327_CR40","doi-asserted-by":"publisher","first-page":"9316","DOI":"10.1038\/s41467-024-53710-7","volume":"15","author":"EF Kot","year":"2024","unstructured":"Kot EF, Goncharuk SA, Franco ML, McKenzie DM, Arseniev AS, Benito-Mart\u00ednez A, Costa M, Cattaneo A, Hristova K, Vilar M, Mineev KS (2024) Structural basis for the transmembrane signaling and antidepressant-induced activation of the receptor tyrosine kinase TrkB. Nat Commun 15(1):9316. https:\/\/doi.org\/10.1038\/s41467-024-53710-7","journal-title":"Nat Commun"},{"key":"7327_CR41","doi-asserted-by":"publisher","unstructured":"Kraemer BR, Yoon SO, Carter BD (2014) The Biological functions and signaling mechanisms of the p75 neurotrophin receptor, pp. 121\u2013164. https:\/\/doi.org\/10.1007\/978-3-642-45106-5_6","DOI":"10.1007\/978-3-642-45106-5_6"},{"issue":"2","key":"7327_CR42","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1084\/jem.186.2.307","volume":"186","author":"JJ Lafaille","year":"1997","unstructured":"Lafaille JJ, Van de Keere F, Hsu AL, Baron JL, Haas W, Raine CS, Tonegawa S (1997) Myelin basic protein\u2013specific T helper 2 (Th2) Cells Cause Experimental Autoimmune Encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J Exp Med 186(2):307\u2013312. https:\/\/doi.org\/10.1084\/jem.186.2.307","journal-title":"J Exp Med"},{"issue":"1","key":"7327_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.expneurol.2011.05.001","volume":"235","author":"JK Lee","year":"2012","unstructured":"Lee JK, Zheng B (2012) Role of myelin-associated inhibitors in axonal repair after spinal cord injury. Exp Neurol 235(1):33\u201342. https:\/\/doi.org\/10.1016\/j.expneurol.2011.05.001","journal-title":"Exp Neurol"},{"issue":"1","key":"7327_CR44","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev.ne.19.030196.001445","volume":"19","author":"GR Lewin","year":"1996","unstructured":"Lewin GR, Barde Y-A (1996) Physiology of the neurotrophins. Annu Rev Neurosci 19(1):289\u2013317. https:\/\/doi.org\/10.1146\/annurev.ne.19.030196.001445","journal-title":"Annu Rev Neurosci"},{"key":"7327_CR45","doi-asserted-by":"publisher","first-page":"e11692","DOI":"10.7554\/eLife.11692","volume":"4","author":"Z Lin","year":"2015","unstructured":"Lin Z, Tann JY, Goh ET, Kelly C, Lim KB, Gao JF, Ibanez CF (2015) Structural basis of death domain signaling in the p75 neurotrophin receptor. ELife 4:e11692. https:\/\/doi.org\/10.7554\/eLife.11692","journal-title":"ELife"},{"issue":"19","key":"7327_CR47","doi-asserted-by":"publisher","first-page":"13026","DOI":"10.1074\/jbc.M113.547018","volume":"289","author":"W Liu","year":"2014","unstructured":"Liu W, Cai M-J, Zheng C-C, Wang J-X, Zhao X-F (2014) Phospholipase C\u03b31 connects the cell membrane pathway to the nuclear receptor pathway in insect steroid hormone signaling. J Biol Chem 289(19):13026\u201313041. https:\/\/doi.org\/10.1074\/jbc.M113.547018","journal-title":"J Biol Chem"},{"issue":"1","key":"7327_CR46","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40035-015-0048-7","volume":"5","author":"C Liu","year":"2016","unstructured":"Liu C, Chan CB, Ye K (2016) 7,8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders. Translational Neurodegeneration 5(1):2. https:\/\/doi.org\/10.1186\/s40035-015-0048-7","journal-title":"Translational Neurodegeneration"},{"issue":"3","key":"7327_CR48","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2174\/157015911796557911","volume":"9","author":"I Loma","year":"2011","unstructured":"Loma I, Heyman R (2011) Multiple sclerosis: pathogenesis and treatment. Curr Neuropharmacol 9(3):409\u2013416. https:\/\/doi.org\/10.2174\/157015911796557911","journal-title":"Curr Neuropharmacol"},{"issue":"8","key":"7327_CR50","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrn1726","volume":"6","author":"B Lu","year":"2005","unstructured":"Lu B, Pang PT, Woo NH (2005) The yin and yang of neurotrophin action. Nat Rev Neurosci 6(8):603\u2013614. https:\/\/doi.org\/10.1038\/nrn1726","journal-title":"Nat Rev Neurosci"},{"key":"7327_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-45106-5_9","author":"B Lu","year":"2014","unstructured":"Lu B, Nagappan G, Lu Y (2014) BDNF and Synaptic plasticity, cognitive function, and dysfunction. Neurotrop Factors. https:\/\/doi.org\/10.1007\/978-3-642-45106-5_9","journal-title":"Neurotrop Factors"},{"issue":"3","key":"7327_CR51","doi-asserted-by":"publisher","first-page":"FSO11","DOI":"10.4155\/fso.15.9","volume":"1","author":"R MacLeod","year":"2015","unstructured":"MacLeod R, Hillert E-K, Cameron RT, Baillie GS (2015) The role and therapeutic targeting of \u03b1-, \u03b2- and \u03b3-secretase in Alzheimer\u2019s disease. Future Sci OA 1(3):FSO11. https:\/\/doi.org\/10.4155\/fso.15.9","journal-title":"Future Sci OA"},{"issue":"1","key":"7327_CR52","doi-asserted-by":"publisher","first-page":"3740461","DOI":"10.1155\/2018\/3740461","volume":"2018","author":"KB Magalingam","year":"2018","unstructured":"Magalingam KB, Radhakrishnan A, Ping NS, Haleagrahara N (2018) Current concepts of neurodegenerative mechanisms in Alzheimer\u2019s disease. BioMed Res Int 2018(1):3740461. https:\/\/doi.org\/10.1155\/2018\/3740461","journal-title":"BioMed Res Int"},{"issue":"2","key":"7327_CR53","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0026-895X(24)23211-9","volume":"57","author":"S Maliartchouk","year":"2000","unstructured":"Maliartchouk S, Feng Y, Ivanisevic L, Debeir T, Cuello AC, Burgess K, Saragovi HU (2000) A designed peptidomimetic agonistic ligand of TrkA nerve growth factor receptors. Mol Pharmacol 57(2):385\u2013391","journal-title":"Mol Pharmacol"},{"issue":"1","key":"7327_CR54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan P, Tabrizi SJ (2018) Huntington\u2019s disease: a clinical review. Eur J Neurol 25(1):24\u201334. https:\/\/doi.org\/10.1111\/ene.13413","journal-title":"Eur J Neurol"},{"issue":"5","key":"7327_CR55","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s11481-014-9566-9","volume":"9","author":"R Meeker","year":"2014","unstructured":"Meeker R, Williams K (2014) Dynamic nature of the p75 neurotrophin receptor in response to injury and disease. J Neuroimmune Pharmacol 9(5):615\u2013628. https:\/\/doi.org\/10.1007\/s11481-014-9566-9","journal-title":"J Neuroimmune Pharmacol"},{"issue":"5","key":"7327_CR56","doi-asserted-by":"publisher","first-page":"721","DOI":"10.4103\/1673-5374.156967","volume":"10","author":"R Meeker","year":"2015","unstructured":"Meeker R, Williams K (2015) The p75 neurotrophin receptor: at the crossroad of neural repair and death. Neural Regen Res 10(5):721. https:\/\/doi.org\/10.4103\/1673-5374.156967","journal-title":"Neural Regen Res"},{"issue":"1","key":"7327_CR58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","volume":"28","author":"DJ Moore","year":"2005","unstructured":"Moore DJ, West AB, Dawson VL, Dawson TM (2005) Molecular pathophysiology of parkinson\u2019s disease. Annu Rev Neurosci 28(1):57\u201387. https:\/\/doi.org\/10.1146\/annurev.neuro.28.061604.135718","journal-title":"Annu Rev Neurosci"},{"issue":"1","key":"7327_CR59","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/cells14010047","volume":"14","author":"KR Moss","year":"2025","unstructured":"Moss KR, Saxena S (2025) Schwann cells in neuromuscular disorders: a spotlight on amyotrophic lateral sclerosis. Cells 14(1):47. https:\/\/doi.org\/10.3390\/cells14010047","journal-title":"Cells"},{"key":"7327_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00205","author":"HTH Nguyen","year":"2019","unstructured":"Nguyen HTH, Wood RJ, Prawdiuk AR, Furness SGB, Xiao J, Murray SS, Fletcher JL (2019) TrkB agonist LM22A-4 increases oligodendroglial populations during myelin repair in the corpus callosum. Front Molecul Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2019.00205","journal-title":"Front Molecul Neurosci"},{"issue":"2","key":"7327_CR61","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.bbr.2010.02.024","volume":"221","author":"G Niewiadomska","year":"2011","unstructured":"Niewiadomska G, Mietelska-Porowska A, Mazurkiewicz M (2011) The cholinergic system, nerve growth factor and the cytoskeleton. Behav Brain Res 221(2):515\u2013526. https:\/\/doi.org\/10.1016\/j.bbr.2010.02.024","journal-title":"Behav Brain Res"},{"issue":"14","key":"7327_CR62","doi-asserted-by":"publisher","first-page":"7726","DOI":"10.3390\/ijms23147726","volume":"23","author":"T Numakawa","year":"2022","unstructured":"Numakawa T, Odaka H (2022) The role of neurotrophin signaling in age-related cognitive decline and cognitive diseases. Int J Mol Sci 23(14):7726. https:\/\/doi.org\/10.3390\/ijms23147726","journal-title":"Int J Mol Sci"},{"issue":"11","key":"7327_CR63","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.mayocp.2018.04.007","volume":"93","author":"B Oskarsson","year":"2018","unstructured":"Oskarsson B, Gendron TF, Staff NP (2018) Amyotrophic lateral sclerosis: an update for 2018. Mayo Clin Proc 93(11):1617\u20131628. https:\/\/doi.org\/10.1016\/j.mayocp.2018.04.007","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"7327_CR30","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1007\/s10072-023-06684-1","volume":"44","author":"JJB Palathoti","year":"2023","unstructured":"Palathoti JJB, Dhanasekaran N, Sivasamy M, Ponnusankar R, Dhanabal S, Sankar SP, V., Justin A (2023) Neurotrophin mimetics and tropomyosin kinase receptors: a futuristic pharmacological tool for Parkinson\u2019s. Neurol Sci 44(7):2265\u20132275. https:\/\/doi.org\/10.1007\/s10072-023-06684-1","journal-title":"Neurol Sci"},{"issue":"3","key":"7327_CR64","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/00001756-199902250-00021","volume":"10","author":"K Parain","year":"1999","unstructured":"Parain K, Murer MG, Yan Q, Faucheux B, Agid Y, Hirsch E, Raisman-Vozari R (1999) Reduced expression of brain-derived neurotrophic factor protein in Parkinson\u02bcs disease substantia nigra. NeuroReport 10(3):557\u2013561. https:\/\/doi.org\/10.1097\/00001756-199902250-00021","journal-title":"NeuroReport"},{"issue":"1","key":"7327_CR65","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11011-021-00800-w","volume":"37","author":"N Pathak","year":"2022","unstructured":"Pathak N, Vimal SK, Tandon I, Agrawal L, Hongyi C, Bhattacharyya S (2022) Neurodegenerative disorders of alzheimer, parkinsonism, amyotrophic lateral sclerosis and multiple sclerosis: an early diagnostic approach for precision treatment. Metab Brain Dis 37(1):67\u2013104. https:\/\/doi.org\/10.1007\/s11011-021-00800-w","journal-title":"Metab Brain Dis"},{"issue":"7","key":"7327_CR66","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1084\/jem.20011797","volume":"195","author":"G Perini","year":"2002","unstructured":"Perini G, Della-Bianca V, Politi V, Della Valle G, Dal-Pra I, Rossi F, Armato U (2002) Role of p75 neurotrophin receptor in the neurotoxicity by \u03b2-amyloid peptides and synergistic effect of inflammatory cytokines. J Exp Med 195(7):907\u2013918. https:\/\/doi.org\/10.1084\/jem.20011797","journal-title":"J Exp Med"},{"issue":"1","key":"7327_CR99","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/msj.20157","volume":"77","author":"DP Perl","year":"2010","unstructured":"Perl DP (2010) Neuropathology of Alzheimer\u2019s Disease. Mt Sinai J Medicine: J Translational Personalized Med 77(1):32\u201342. https:\/\/doi.org\/10.1002\/msj.20157","journal-title":"Mt Sinai J Medicine: J Translational Personalized Med"},{"issue":"3","key":"7327_CR100","doi-asserted-by":"publisher","first-page":"84","DOI":"10.32607\/20758251-2013-5-3-84-91","volume":"5","author":"PY Povarnina","year":"2013","unstructured":"Povarnina PY, Vorontsova ON, Gudasheva TA, Ostrovskaya RU, Seredenin SB (2013) Original Nerve Growth Factor Mimetic Dipeptide GK-2 Restores Impaired Cognitive Functions in Rat Models of Alzheimer\u2019s Disease. Acta Naturae 5(3):84\u201391","journal-title":"Acta Naturae"},{"issue":"3\u20134","key":"7327_CR67","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S1359-6101(03)00018-2","volume":"14","author":"S Rabizadeh","year":"2003","unstructured":"Rabizadeh S, Bredesen DE (2003) Ten years on: mediation of cell death by the common neurotrophin receptor p75NTR. Cytokine Growth Factor Rev 14(3\u20134):225\u2013239. https:\/\/doi.org\/10.1016\/S1359-6101(03)00018-2","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1261","key":"7327_CR68","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1098\/rstb.1991.0013","volume":"331","author":"A Rodr\u00edguez-T\u00e9bar","year":"1991","unstructured":"Rodr\u00edguez-T\u00e9bar A, Dechant G, Barde Y, -a (1991) Neurotrophins: structural relatedness and receptor interactions. Philosophical Trans Royal Soc Lond Ser B: Biol Sci 331(1261):255\u2013258. https:\/\/doi.org\/10.1098\/rstb.1991.0013","journal-title":"Philosophical Trans Royal Soc Lond Ser B: Biol Sci"},{"issue":"3","key":"7327_CR101","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3390\/biomedicines10030614","volume":"10","author":"T Rogdakis","year":"2022","unstructured":"Rogdakis T, Charou D, Latorrata A, Papadimitriou E, Tsengenes A, Athanasiou C, Papadopoulou M, Chalikiopoulou C, Katsila T, Ramos I, Prousis KC, Wade RC, Sidiropoulou K, Calogeropoulou T, Gravanis A, Charalampopoulos I (2022b) Development and Biological Characterization of a Novel Selective TrkA Agonist with Neuroprotective Properties against Amyloid Toxicity. Biomedicines 10(3):614. https:\/\/doi.org\/10.3390\/biomedicines10030614","journal-title":"Biomedicines"},{"issue":"3","key":"7327_CR69","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3390\/biomedicines10030614","volume":"10","author":"T Rogdakis","year":"2022","unstructured":"Rogdakis T, Charou D, Latorrata A, Papadimitriou E, Tsengenes A, Athanasiou C, Papadopoulou M, Chalikiopoulou C, Katsila T, Ramos I, Prousis KC, Wade RC, Sidiropoulou K, Calogeropoulou T, Gravanis A, Charalampopoulos I (2022a) Development and biological characterization of a novel selective TrkA agonist with neuroprotective properties against amyloid toxicity. Biomedicines 10(3):614. https:\/\/doi.org\/10.3390\/biomedicines10030614","journal-title":"Biomedicines"},{"issue":"1","key":"7327_CR70","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos RA (2010) Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis 5(1):40. https:\/\/doi.org\/10.1186\/1750-1172-5-40","journal-title":"Orphanet J Rare Dis"},{"key":"7327_CR71","doi-asserted-by":"publisher","first-page":"917527","DOI":"10.3389\/fneur.2022.917527","volume":"13","author":"G Schir\u00f2","year":"2022","unstructured":"Schir\u00f2 G, Iacono S, Ragonese P, Aridon P, Salemi G, Balistreri CR (2022) A brief overview on BDNF-Trk pathway in the nervous system: a potential biomarker or possible target in treatment of multiple sclerosis? Front Neurol 13:917527. https:\/\/doi.org\/10.3389\/fneur.2022.917527","journal-title":"Front Neurol"},{"issue":"32","key":"7327_CR72","doi-asserted-by":"publisher","first-page":"25910","DOI":"10.1039\/D5RA03578C","volume":"15","author":"D Senanayake","year":"2025","unstructured":"Senanayake D, Yapa P, Dabare S, Munaweera I (2025) Precision targeting of the CNS: recent progress in brain-directed nanodrug delivery. RSC Adv 15(32):25910\u201325928. https:\/\/doi.org\/10.1039\/D5RA03578C","journal-title":"RSC Adv"},{"issue":"1","key":"7327_CR73","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harbor Perspect Med 1(1):a006189\u2013a006189. https:\/\/doi.org\/10.1101\/cshperspect.a006189","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"7327_CR102","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neurobiolaging.2019.07.018","volume":"84","author":"A Shekari","year":"2019","unstructured":"Shekari A, Fahnestock M (2019) Retrograde axonal transport of BDNF and proNGF diminishes with age in basal forebrain cholinergic neurons. Neurobiol Aging 84:131\u2013140. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.07.018","journal-title":"Neurobiol Aging"},{"issue":"7","key":"7327_CR74","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.3390\/ijms27073238","volume":"27","author":"C Siddi","year":"2026","unstructured":"Siddi C, Balla J, Fadda P, Dedoni S (2026) Epigenetic regulation of Trk Receptors and neurotrophic signalling in neuroblastoma: mechanisms, plasticity, and therapeutic opportunities. Int J Mol Sci 27(7):3238. https:\/\/doi.org\/10.3390\/ijms27073238","journal-title":"Int J Mol Sci"},{"key":"7327_CR75","doi-asserted-by":"publisher","unstructured":"Simmons DA, Belichenko NP, Ford EC, Semaan S, Monbureau M, Aiyaswamy S, Holman CM, Condon C, Shamloo M, Massa SM, Longo FM (2016) A small molecule p75 NTR ligand normalizes signalling and reduces Huntington\u2019s disease phenotypes in R6\/2 and BACHD mice. Hum Mol Genet ddw316. https:\/\/doi.org\/10.1093\/hmg\/ddw316","DOI":"10.1093\/hmg\/ddw316"},{"issue":"3","key":"7327_CR76","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3233\/JHD-230589","volume":"12","author":"DA Simmons","year":"2023","unstructured":"Simmons DA, Belichenko NP, Longo FM (2023) Pharmacological co-activation of TrkB and TrkC receptor signaling ameliorates striatal neuropathology and motor deficits in mouse models of huntington\u2019s disease. J Huntington\u2019s Disease 12(3):215\u2013239. https:\/\/doi.org\/10.3233\/JHD-230589","journal-title":"J Huntington\u2019s Disease"},{"issue":"1","key":"7327_CR77","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/npp.2011.212","volume":"37","author":"Y Smith","year":"2012","unstructured":"Smith Y, Wichmann T, Factor SA, DeLong MR (2012) Parkinson\u2019s disease therapeutics: new developments and challenges since the introduction of Levodopa. Neuropsychopharmacology 37(1):213\u2013246. https:\/\/doi.org\/10.1038\/npp.2011.212","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"7327_CR78","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/cne.903500407","volume":"350","author":"T Sobreviela","year":"1994","unstructured":"Sobreviela T, Clary DO, Reichardt LF, Brandabur MM, Kordower JH, Mufson EJ (1994) TrkA-immunoreactive profiles in the central nervous system: Colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin. J Comp Neurol 350(4):587\u2013611. https:\/\/doi.org\/10.1002\/cne.903500407","journal-title":"J Comp Neurol"},{"issue":"1","key":"7327_CR79","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1582-4934.2005.tb00337.x","volume":"9","author":"G Song","year":"2005","unstructured":"Song G, Ouyang G, Bao S (2005) The activation of Akt\/PKB signaling pathway and cell survival. J Cell Mol Med 9(1):59\u201371. https:\/\/doi.org\/10.1111\/j.1582-4934.2005.tb00337.x","journal-title":"J Cell Mol Med"},{"issue":"2","key":"7327_CR80","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1460-9568.1995.tb01058.x","volume":"7","author":"L Studer","year":"1995","unstructured":"Studer L, Spenger C, Seiler RW, Altar CA, Lindsay RM, Hyman C (1995) Comparison of the effects of the neurotrophins on the morphological structure of dopaminergic neurons in cultures of rat substantia Nigra. Eur J Neurosci 7(2):223\u2013233. https:\/\/doi.org\/10.1111\/j.1460-9568.1995.tb01058.x","journal-title":"Eur J Neurosci"},{"issue":"7","key":"7327_CR81","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2174\/1389203711209070658","volume":"14","author":"X-L Sun","year":"2013","unstructured":"Sun X-L, Chen B-Y, Xia Y, Wang J-J, Chen L-W (2013) Functional switch from pro-neurotrophins to mature neurotrophins. Curr Protein Pept Sci 14(7):617\u2013625. https:\/\/doi.org\/10.2174\/1389203711209070658","journal-title":"Curr Protein Pept Sci"},{"issue":"11","key":"7327_CR82","doi-asserted-by":"publisher","first-page":"8950","DOI":"10.3390\/cimb45110562","volume":"45","author":"S Terracina","year":"2023","unstructured":"Terracina S, Ferraguti G, Tarani L, Fanfarillo F, Tirassa P, Ralli M, Iannella G, Polimeni A, Lucarelli M, Greco A, Fiore M (2023) Nerve growth factor and autoimmune diseases. Curr Issues Mol Biol 45(11):8950\u20138973. https:\/\/doi.org\/10.3390\/cimb45110562","journal-title":"Curr Issues Mol Biol"},{"issue":"15","key":"7327_CR83","doi-asserted-by":"publisher","first-page":"15233","DOI":"10.1021\/acs.jmedchem.4c02365","volume":"68","author":"TS Thompson","year":"2025","unstructured":"Thompson TS, Sefiani A, Burgess K (2025) Small-molecule Trk agonists: Where do we go from here? J Med Chem 68(15):15233\u201315259. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c02365","journal-title":"J Med Chem"},{"issue":"9","key":"7327_CR84","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.3390\/ijms26094271","volume":"26","author":"C Toader","year":"2025","unstructured":"Toader C, Serban M, Munteanu O, Covache-Busuioc R-A, Enyedi M, Ciurea AV, Tataru CP (2025) From Synaptic plasticity to neurodegeneration: BDNF as a transformative target in medicine. Int J Mol Sci 26(9):4271. https:\/\/doi.org\/10.3390\/ijms26094271","journal-title":"Int J Mol Sci"},{"issue":"8","key":"7327_CR85","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1021\/jm3015926","volume":"56","author":"PC Trippier","year":"2013","unstructured":"Trippier PC, Labby J, Hawker K, Mataka DD, J. J., Silverman RB (2013) Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers. J Med Chem 56(8):3121\u20133147. https:\/\/doi.org\/10.1021\/jm3015926","journal-title":"J Med Chem"},{"issue":"6","key":"7327_CR103","doi-asserted-by":"publisher","first-page":"8094","DOI":"10.1002\/jcp.27588","volume":"234","author":"S Uddin,Md","year":"2019","unstructured":"Uddin, Md S, Mamun A, Al, Labu ZK, Hidalgo\u2010Lanussa O, Barreto GE, Ashraf GM (2019) Autophagic dysfunction in Alzheimer\u2019s disease: Cellular and molecular mechanistic approaches to halt Alzheimer\u2019s pathogenesis. J Cell Physiol 234(6):8094\u20138112. https:\/\/doi.org\/10.1002\/jcp.27588","journal-title":"J Cell Physiol"},{"issue":"1","key":"7327_CR104","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1750-1326-9-34","volume":"9","author":"R Vassar","year":"2014","unstructured":"Vassar R, Zheng H (2014) Molecular neurodegeneration: basic biology and disease pathways. Mol Neurodegeneration 9(1):34. https:\/\/doi.org\/10.1186\/1750-1326-9-34","journal-title":"Mol Neurodegeneration"},{"issue":"6749","key":"7327_CR86","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/43705","volume":"401","author":"C Wiesmann","year":"1999","unstructured":"Wiesmann C, Ultsch MH, Bass SH, de Vos AM (1999) Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor. Nature 401(6749):184\u2013188. https:\/\/doi.org\/10.1038\/43705","journal-title":"Nature"},{"key":"7327_CR87","doi-asserted-by":"publisher","first-page":"103105","DOI":"10.1016\/j.arr.2026.103105","volume":"118","author":"J Wu","year":"2026","unstructured":"Wu J, Ma H, Niu X, Zhang Z, Guo R, Shen N, Tian Y, Zhao H, Yang Y, Chen Y (2026) The p75NTR signaling axis: bridging neurodevelopmental homeostasis, pathological mechanisms, and therapeutic strategies in neurodegenerative diseases. Ageing Res Rev 118:103105. https:\/\/doi.org\/10.1016\/j.arr.2026.103105","journal-title":"Ageing Res Rev"},{"issue":"4","key":"7327_CR89","doi-asserted-by":"publisher","first-page":"eaax6646","DOI":"10.1126\/sciadv.aax6646","volume":"6","author":"K Xhima","year":"2020","unstructured":"Xhima K, Markham-Coultes K, Nedev H, Heinen S, Saragovi HU, Hynynen K, Aubert I (2020) Focused ultrasound delivery of a selective TrkA agonist rescues cholinergic function in a mouse model of Alzheimer\u2019s disease. Sci Adv 6(4):eaax6646. https:\/\/doi.org\/10.1126\/sciadv.aax6646","journal-title":"Sci Adv"},{"issue":"8","key":"7327_CR88","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1093\/brain\/awab460","volume":"145","author":"K Xhima","year":"2022","unstructured":"Xhima K, Markham-Coultes K, Hahn Kofoed R, Saragovi HU, Hynynen K, Aubert I (2022) Ultrasound delivery of a TrkA agonist confers neuroprotection to Alzheimer-associated pathologies. Brain 145(8):2806\u20132822. https:\/\/doi.org\/10.1093\/brain\/awab460","journal-title":"Brain"},{"issue":"3","key":"7327_CR90","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.celrep.2014.03.040","volume":"7","author":"J Yang","year":"2014","unstructured":"Yang J, Harte-Hargrove LC, Siao C-J, Marinic T, Clarke R, Ma Q, Jing D, LaFrancois JJ, Bath KG, Mark W, Ballon D, Lee FS, Scharfman HE, Hempstead BL (2014) proBDNF negatively regulates neuronal remodeling, synaptic transmission, and synaptic plasticity in hippocampus. Cell Rep 7(3):796\u2013806. https:\/\/doi.org\/10.1016\/j.celrep.2014.03.040","journal-title":"Cell Rep"},{"issue":"7","key":"7327_CR91","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3390\/pharmaceutics15071899","volume":"15","author":"C Yao","year":"2023","unstructured":"Yao C, Zhang D, Wang H, Zhang P (2023) Recent advances in cell membrane coated-nanoparticles as drug delivery systems for tackling urological diseases. Pharmaceutics 15(7):1899. https:\/\/doi.org\/10.3390\/pharmaceutics15071899","journal-title":"Pharmaceutics"},{"issue":"2","key":"7327_CR92","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/msj.20244","volume":"78","author":"J Zhang","year":"2011","unstructured":"Zhang J, Kramer EG, Mahase S, Dutta DJ, Bonnamain V, Argaw AT, John GR (2011) Targeting oligodendrocyte protection and remyelination in multiple sclerosis. Mt Sinai J Med J Transl Personal Med 78(2):244\u2013257. https:\/\/doi.org\/10.1002\/msj.20244","journal-title":"Mt Sinai J Med J Transl Personal Med"},{"issue":"5529","key":"7327_CR93","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1126\/science.1059581","volume":"293","author":"C Zuccato","year":"2001","unstructured":"Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L, MacDonald ME, Friedlander RM, Silani V, Hayden MR, Timmusk T, Sipione S, Cattaneo E (2001) Loss of huntingtin-mediated BDNF gene transcription in huntington\u2019s disease. Science 293(5529):493\u2013498. https:\/\/doi.org\/10.1126\/science.1059581","journal-title":"Science"}],"container-title":["Experimental Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00221-026-07327-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00221-026-07327-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00221-026-07327-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:41:50Z","timestamp":1782924110000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00221-026-07327-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":103,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["7327"],"URL":"https:\/\/doi.org\/10.1007\/s00221-026-07327-5","relation":{},"ISSN":["0014-4819","1432-1106"],"issn-type":[{"value":"0014-4819","type":"print"},{"value":"1432-1106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"129"}}